nonprofit logo

Pharmaceutical Security Institute Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 010549023 ✦ Vienna, VA ✦ Designated as a 501(c)(6)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Pharmaceutical Security Institute Inc?

Pharmaceutical Security Institute Inc, based in Vienna, Virginia, serves as a nonprofit organization dedicated to combating the issue of counterfeit, stolen, and illegally diverted medicines. They collect, analyze, and disseminate relevant information on this matter to various stakeholders, including their members, law enforcement agencies, customs agents, and drug regulators. Their mission extends beyond the organization, reaching out to the public as well. During their operations, they identified and analyzed over 36,000 reports of such incidents, identifying approximately 6,600 unique cases. They share their findings with international organizations like the World Health Organization and national authorities within the U.S., including the Food and Drug Administration and the Department of Homeland Security's IPR Center. With a workforce of 6 employees, Pharmaceutical Security Institute Inc works tirelessly to combat this widespread problem in the pharmaceutical sector.


Official website here: www.psi-inc.org

Is Pharmaceutical Security Institute Inc legitimate?

Pharmaceutical Security Institute Inc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Pharmaceutical Security Institute Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $321,269
Professional Fundraising Fees: $0
Other Salaries and Wages: $569,436

For more financial information, click here


Official website here: www.psi-inc.org

What is the mission statement of Pharmaceutical Security Institute Inc?

The Pharmaceutical Security Institute Inc is committed to combating the counterfeiting of medications. They accomplish this by gathering, analyzing, and disseminating relevant information about counterfeit medicines to various stakeholders, including their members, law enforcement agencies, customs agents, and drug regulators, as well as the general public. The Institute's activities have led to the identification and analysis of over 36,000 reports of counterfeit, stolen, or illegally diverted medicines. They have determined that approximately 6,600 of these reports contained unique instances of counterfeit medicines. The Institute has prepared abstracts for over 2,200 public reports related to the counterfeiting, illegal diversion, or theft of medicines, and has shared their findings with international organizations such as the World Health Organization. They also provide this information to national authorities within the United States, including the Food and Drug Administration and the FBI, among others.


Official website here: www.psi-inc.org

Who is the CEO of Pharmaceutical Security Institute Inc?

C Todd Ratcliffe is the Chairperson of Pharmaceutical Security Institute Inc. The CEO's salary of Pharmaceutical Security Institute Inc is $314,391 and their total compensation is $321,269.


Official website here: www.psi-inc.org

What is the revenue of Pharmaceutical Security Institute Inc?

Pharmaceutical Security Institute Inc's revenue in 2022 was $2,254,106.


Official website here: www.psi-inc.org

Who are the executives of Pharmaceutical Security Institute Inc and what are their salaries?

The average compensation at Pharmaceutical Security Institute Inc during 2022 was $148,451. There are 6 employees at Pharmaceutical Security Institute Inc.


Here are 12 key members and their salaries (Pharmaceutical Security Institute Inc's CEO's salary is $314,391 and their total compensation is $321,269):


Amy Lyons (Chairperson)
  • Compensation: $0
  • Related: $0
  • Other: $0
Gregory Kleiman (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Reznick (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lev Kubiak (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Thomas Cueni (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Trevor Rees (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stanislas Barro (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
C Todd Ratcliffe (President And Ceo)
  • Compensation: $314,391
  • Related: $0
  • Other: $6,878
Eddie Agrait (Regional Manager)
  • Compensation: $133,000
  • Related: $0
  • Other: $0
Cecilia Fant (Regional Manager)
  • Compensation: $102,381
  • Related: $0
  • Other: $8,765
Peter York (Global Intelligence Manage)
  • Compensation: $126,000
  • Related: $0
  • Other: $26,632
Ramesh Raj Kishore (Regional Director)
  • Compensation: $111,553
  • Related: $0
  • Other: $10,919


Official website here: www.psi-inc.org

Where can I find the form 990 for Pharmaceutical Security Institute Inc?

Pharmaceutical Security Institute Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.psi-inc.org

Learn more at the official website: www.psi-inc.org

Mission Statement of Pharmaceutical Security Institute Inc

The Pharmaceutical Security Institute Inc is dedicated to combating the issue of counterfeit medications. Their primary objective is to gather, analyze, and disseminate relevant information about this problem to various stakeholders, including their members, law enforcement agencies, customs agents, drug regulators, and the general public. By doing so, they aim to safeguard public health and prevent the distribution of harmful counterfeit medicines.

In their mission, Pharmaceutical Security Institute Inc collects and analyzes numerous reports of counterfeit, stolen, or illegally diverted medicines. This extensive data collection is a crucial step in identifying unique cases of medication fraud. Following the analysis, they prepare summaries of the most significant reports and share these findings with international organizations, such as the World Health Organization and Interpol, as well as national authorities within the US, including the Food and Drug Administration and the Department of Homeland Security's IPR Center. This collaborative approach helps to combat the global issue of medication counterfeiting and protect public health.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Pharmaceutical Security Institute Inc (PSI) significantly impacts global health by combatting the counterfeit drug crisis. By collecting, analyzing, and disseminating critical information regarding counterfeit, stolen, and illegally diverted medicines, PSI enhances the ability of law enforcement, regulatory agencies, and public health organizations to protect consumers and ensure the integrity of the pharmaceutical supply chain.

In recent years, PSI has identified and analyzed over 36,000 reports of counterfeit and diverted medicinal products, including approximately 6,600 unique cases. This wealth of data is vital for understanding the scope and nature of drug counterfeiting, enabling better preventive measures and response strategies by authorities. PSI has also prepared detailed reports and abstracts, effectively communicating relevant findings to international organizations such as the World Health Organization and INTERPOL, as well as national agencies like the FDA and FBI.

By equipping these stakeholders with actionable intelligence, PSI plays a crucial role in reducing the prevalence of counterfeit medicines, thereby safeguarding public health and restoring trust in healthcare systems worldwide. Whether through direct collaboration or facilitating the exchange of information, PSI's contributions are vital in the ongoing fight against pharmaceutical crime.




This information is meant to be a general summary of Pharmaceutical Security Institute Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$2,254,106 (2022)
Expenses
$1,854,717 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: -$4,890
  • Program Service Revenue: $2,258,996
  • Gross Receipts: $2,266,164

Assets and Liabilities:

  • Total Assets: $3,376,183
  • Total Liabilities: $431,285
  • Net Assets: $2,944,898

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

MEMBERSHIP DUES

Revenue

$1,909,917

SPECIAL PROJECTS REV

Revenue

$349,079

Organization Details

Founding Year

2001

Principal Officer

C Todd Ratcliffe

Main Address

8100 BOONE BLVD 220, VIENNA, VA, 22182

NTEE Category

Code: E03 - Health

If you are a representative of Pharmaceutical Security Institute Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.